Robert C Millikan Selected Research

Progesterone

1/2016	Vehicular Traffic-Related Polycyclic Aromatic Hydrocarbon Exposure and Breast Cancer Incidence: The Long Island Breast Cancer Study Project (LIBCSP).
1/2015	Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects.
10/2005	High focal adhesion kinase expression in invasive breast carcinomas is associated with an aggressive phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Robert C Millikan Research Topics

Disease

46	Breast Neoplasms (Breast Cancer) 07/2016 - 05/2003
30	Neoplasms (Cancer) 07/2016 - 05/2003
15	Colonic Neoplasms (Colon Cancer) 11/2014 - 02/2003
7	Melanoma (Melanoma, Malignant) 01/2012 - 03/2006
5	Carcinogenesis 08/2013 - 09/2005
4	Inflammation (Inflammations) 10/2011 - 12/2003
3	Obesity 09/2012 - 01/2009
3	Colorectal Neoplasms (Colorectal Cancer) 01/2010 - 03/2006
2	Insulin Resistance 10/2011 - 01/2009
2	Atherosclerosis 10/2011 - 12/2003
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2009 - 02/2007
2	Weight Loss (Weight Reduction) 01/2009 - 01/2009
2	Adenoma (Adenomas) 08/2008 - 03/2006
2	Hypersensitivity (Allergy) 12/2006 - 01/2005
2	Carcinoma in Situ 12/2003 - 05/2003
1	Rectal Neoplasms (Rectal Cancer) 01/2010
1	Overweight 01/2009
1	Aneuploidy (Aneuploid) 04/2007
1	Neoplasm Metastasis (Metastasis) 04/2007
1	Hyperplasia 01/2007

Drug/Important Bio-Agent (IBA)

11	ORALIT (ORS)IBA 12/2015 - 05/2003
10	Estrogen ReceptorsIBA 01/2015 - 06/2006
9	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 01/2004
9	Phenobarbital (Luminal)FDA Link 12/2015 - 06/2006
7	Estrogens (Estrogen)FDA Link 01/2016 - 01/2004
6	Proteins (Proteins, Gene)FDA Link 07/2016 - 12/2006
6	Hormones (Hormone)IBA 01/2016 - 01/2005
5	Biomarkers (Surrogate Marker)IBA 12/2012 - 12/2006
5	Codon (Codons)IBA 07/2006 - 01/2005
3	Progesterone FDA LinkGeneric 01/2016 - 10/2005
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2015 - 10/2011
3	CarcinogensIBA 11/2014 - 07/2005
3	Estrogen Receptor alphaIBA 02/2014 - 01/2005
3	AdiponectinIBA 10/2011 - 01/2009
3	Trans Fatty AcidsIBA 01/2010 - 08/2008
3	Folic Acid (Vitamin M)FDA LinkGeneric 01/2009 - 08/2005
3	Biological ProductsIBA 01/2009 - 01/2007
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 04/2006 - 12/2003
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2016 - 01/2016
2	Benzo(a)pyreneIBA 01/2016 - 09/2008
2	Sex Hormone-Binding GlobulinIBA 01/2015 - 01/2009
2	AminesIBA 11/2014 - 02/2008
2	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2014 - 08/2010
2	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 08/2013 - 11/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2013 - 01/2004
2	ErbB Receptors (EGF Receptor)IBA 01/2013 - 02/2007
2	Keratin-5 (Keratin 5)IBA 01/2013 - 02/2007
2	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012 - 12/2011
2	Epidermal Growth Factor (EGF)IBA 10/2011 - 06/2006
2	LeptinIBA 09/2011 - 01/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2011 - 08/2005
2	Tamoxifen FDA LinkGeneric 01/2011 - 05/2009
2	human ERBB2 proteinIBA 12/2010 - 05/2008
2	Indicators and Reagents (Reagents)IBA 11/2010 - 05/2008
2	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2009 - 10/2005
2	Oral ContraceptivesIBA 05/2009 - 01/2007
2	SeleniumIBA 01/2009 - 03/2006
2	N-acetyltransferase 1IBA 02/2008 - 02/2003
2	Cyclin EIBA 04/2007 - 11/2006
2	SmokeIBA 05/2006 - 01/2004
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 01/2005 - 01/2004
1	Aurora Kinase AIBA 12/2015
1	Cytochrome P450 Family 19IBA 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Hydroxysteroid DehydrogenasesIBA 01/2015
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2014
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2014
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 10/2014
1	MMEIBA 10/2014
1	ribosomal protein S30IBA 02/2014
1	MAP Kinase Kinase Kinase 1IBA 02/2014
1	AcetaldehydeIBA 08/2013
1	MicroRNAs (MicroRNA)IBA 06/2013
1	AntioxidantsIBA 12/2012
1	Opioid Analgesics (Opioids)IBA 04/2012
1	Opioid Receptors (Opioid Receptor)IBA 04/2012
1	Dihydrotachysterol (AT 10)IBA 04/2012
1	Vitamin D FDA LinkGeneric 12/2011
1	AdipokinesIBA 09/2011
1	Leptin ReceptorsIBA 09/2011
1	Hydroxymethylglutaryl CoA Reductases (HMG CoA Reductase)IBA 01/2011
1	Messenger RNA (mRNA)IBA 01/2011
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 08/2010
1	Claudin-4IBA 05/2009
1	C-Reactive ProteinIBA 01/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2009
1	AndrogensIBA 01/2009
1	Trace Elements (Biometals)IBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Estrone FDA Link 01/2009
1	SurvivinIBA 05/2008
1	methionine synthase reductaseIBA 01/2008
1	Glycine Hydroxymethyltransferase (Serine Hydroxymethyltransferase)IBA 01/2008
1	5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA 01/2008
1	CarbonIBA 01/2008
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2007
1	Telomerase (Telomerase Reverse Transcriptase)IBA 04/2007
1	centromere protein FIBA 04/2007

Therapy/Procedure

2	Therapeutics 07/2016 - 08/2010
1	Treatment Delay 07/2013